810 related articles for article (PubMed ID: 16645971)
1. Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.
Shin IS; Baer AN; Kwon HJ; Papadopoulos EJ; Siegel JN
Arthritis Rheum; 2006 May; 54(5):1429-34. PubMed ID: 16645971
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.
Silburn S; McIvor E; McEntegart A; Wilson H
Ann Rheum Dis; 2008 Apr; 67(4):575-6. PubMed ID: 18349168
[No Abstract] [Full Text] [Related]
3. Miller fisher variant of guillain-barre syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation.
Kaushik P; Cohen AJ; Zuckerman SJ; Vatsavai SR; Pepper JS; Banda VR; Eason JD; Loss GE; Kaushik R
Ann Pharmacother; 2005 Jun; 39(6):1124-7. PubMed ID: 15855240
[TBL] [Abstract][Full Text] [Related]
4. Miller Fisher syndrome: axonal, demyelinating or both?
Scelsa SN; Herskovitz S
Electromyogr Clin Neurophysiol; 2000 Dec; 40(8):497-502. PubMed ID: 11155543
[TBL] [Abstract][Full Text] [Related]
5. [Eczematous reactions after intravenous immunoglobulin therapy in two patients with Guillain-Barré syndrome and a patient with Miller Fisher syndrome].
Tada M; Tada M; Ishiguro H; Yagi E; Hirota K
No To Shinkei; 2003 May; 55(5):401-5. PubMed ID: 12833881
[TBL] [Abstract][Full Text] [Related]
6. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
7. Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
Simsek I; Erdem H; Pay S; Sobaci G; Dinc A
Ann Rheum Dis; 2007 Sep; 66(9):1255-8. PubMed ID: 17456525
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy.
Bouchra A; Benbouazza K; Hajjaj-Hassouni N
Clin Rheumatol; 2009 Jun; 28 Suppl 1():S53-5. PubMed ID: 19277812
[TBL] [Abstract][Full Text] [Related]
9. [Ataxic Guillain-Barré syndrome with delayed facial diplegia].
Atsumi M; Kitaguchi M; Chimoto Y; Nishikawa S; Mineta H; Nakasaka Y; Tanaka H; Susuki K
Rinsho Shinkeigaku; 2003 Sep; 43(9):548-51. PubMed ID: 14727561
[TBL] [Abstract][Full Text] [Related]
10. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
12. Miller Fisher syndrome--an uncommon clinical presentation.
Santra G; Datta AK
J Assoc Physicians India; 2008 Nov; 56():898-900. PubMed ID: 19263690
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
14. [Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].
de Oliveira SK; de Almeida RG; Fonseca AR; Rodrigues MC; Sztajnbok F; Diniz C
Acta Reumatol Port; 2007; 32(2):139-50. PubMed ID: 17572652
[TBL] [Abstract][Full Text] [Related]
15. [Miller-Fisher syndrome].
Jørgensen L; Vedeler CA
Tidsskr Nor Laegeforen; 2005 May; 125(10):1327-8. PubMed ID: 15909003
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiologic study of 10 cases of Miller Fisher syndrome].
Durand MC; Goulon-Goéau C; Schweitzer A; Chéliout-Héraut F; Raphael JC; Gajdos P
Rev Neurol (Paris); 2001 Jan; 157(1):72-9. PubMed ID: 11240551
[TBL] [Abstract][Full Text] [Related]
17. Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis.
Wu E; Chen L; Birnbaum H; Yang E; Cifaldi M
Curr Med Res Opin; 2008 Aug; 24(8):2229-40. PubMed ID: 18577308
[TBL] [Abstract][Full Text] [Related]
18. Association of tumor necrosis factor polymorphisms with Guillain-Barré syndrome.
Zhang J; Dong H; Li B; Li CY; Guo L
Eur Neurol; 2007; 58(1):21-5. PubMed ID: 17483581
[TBL] [Abstract][Full Text] [Related]
19. [Anti-GD1b IgG positive case of overlapping Ficher's and Guillain-Barré syndromes].
Caudie C; Schandelong A; Rapoport F; Vial C
Ann Biol Clin (Paris); 2004; 62(5):591-4. PubMed ID: 15355812
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
